LONDON — Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion).
British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will LONDON | GSK, Pfizer to merge their healthcare divisions
LONDON — Drugmakers GlaxoSmithKline and Pfizer are merging their healthcare divisions, creating a business with combined sales of 9.8 billion pounds ($12.7 billion).
British-based Glaxo will own 68 percent of the joint venture, while U.S.-based Pfizer will Subscribe to iCameroon.Com Newsletter
